XenoPort, Inc.
(NASDAQ : XNPT)

( )
XNPT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc.
-0.03%98.252.1%$1117.81m
JNJJohnson & Johnson
-0.18%121.830.6%$814.52m
PFEPfizer Inc.
-0.47%36.300.9%$736.55m
MRKMerck & Co., Inc.
-0.18%61.180.6%$617.69m
BMYBristol-Myers Squibb Company
0.24%54.401.4%$372.95m
LLYEli Lilly and Company
-0.04%86.281.0%$311.41m
NVSNovartis AG Sponsored ADR
0.00%74.240.2%$119.71m
SNYSanofi Sponsored ADR
0.28%39.520.2%$108.81m
AZNAstraZeneca PLC Sponsored ADR
-1.07%35.741.3%$107.33m
GSKGlaxoSmithKline plc Sponsored ADR
-1.05%40.600.2%$86.65m
NVONovo Nordisk A/S Sponsored ADR Class B
2.80%46.930.1%$76.24m

Company Profile

XenoPort, Inc. operates as a biopharmaceutical company. Its products include horizant and regnite. The company is headquartered in was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on May 19, 1999 and is headquartered in Redwood City, CA.